2011.03.10 Weekly Broadcast Email

The following update was made to the CCCWFU CCOP Research Base website for the week of March 7, 2011.


 98110:(A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy)

Amendment 2 has been added to the website. This amendment includes protocol, consent and appendix changes.

 

Lisa Autry-

Quick Reference

Research Base

Phone 336-716-0891
Fax 336-716-6275

E-mail
resbase@wakehealth.edu

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 05-11-2015
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.